Implantable insulin pumps are transforming diabetes management by offering a precise, continuous insulin delivery system directly into the body. This technology reduces the need for multiple daily injections and enhances glycemic control for individuals with Type 1 and insulin-dependent Type 2 diabetes. The report dives into the advancements in microelectromechanical systems (MEMS), s... https://www.uniprismmarketresearch.com/verticals/healthcare/injectable-cytotoxic-drugs